CIBC Asset Management
LAB icon

CIBC Asset Management’s Standard BioTools LAB Stock Holding History

CIBC Asset Management’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.92K Sell
12,062
-13,377
-53% -$12.6K ﹤0.01% 1427
2026
Q1 		$23.4K Hold
25,439
– – ﹤0.01% 1367
2025
Q4 		$32.6K Buy
+25,439
New +$34.2K ﹤0.01% 1357

Other funds holding LAB

CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $504M AUM 26.89% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

CIBC Asset Management's LAB Position: Q2 2026 in Review

CIBC Asset Management reduced its Standard BioTools (LAB) stake by 53% in Q2 2026, selling an estimated $12.6K and leaving 12,062 shares worth $9.92K. The position accounts for ﹤0.01% of the portfolio, ranked #1427.

CIBC Asset Management first reported a position in LAB in Q4 2025 and has held it in 3 quarters since. The position peaked at $32.6K in Q4 2025. 143 funds tracked by Wall St. Rank hold LAB as of Q2 2026.

  • CIBC Asset Management held 12,062 shares of Standard BioTools worth $9.92K as of Q2 2026.
  • CIBC Asset Management sold 13,377 Standard BioTools shares in Q2 2026, an estimated $12.6K.
  • Standard BioTools made up ﹤0.01% of CIBC Asset Management's portfolio in Q2 2026, its #1427 holding.
  • CIBC Asset Management first reported a position in Standard BioTools in Q4 2025 and has held it in 3 quarters since.
  • CIBC Asset Management's Standard BioTools position peaked at $32.6K in Q4 2025.
  • 143 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2026.

Based on CIBC Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.